{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T12:50:07Z","timestamp":1791809407497,"version":"4.3.4"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Early onset ataxia with ocular motor apraxia and hypoalbuminaemia\/ataxia\u2013oculomotor apraxia 1 is a recessively inherited ataxia caused by mutations in the aprataxin gene. We previously reported that patients with frameshift mutations exhibit a more severe phenotype than those with missense mutations. However, reports on genotype\u2013phenotype correlation in early onset ataxia with ocular motor apraxia and hypoalbuminaemia are controversial. To clarify this issue, we studied 58 patients from 39 Japanese families, including 40 patients homozygous for c.689_690insT and nine patients homozygous or compound heterozygous for p.Pro206Leu or p.Val263Gly mutations who were compared with regard to clinical phenotype. We performed Kaplan\u2013Meier analysis and log-rank tests for the ages of onset of gait disturbance and the inability to walk without assistance. The cumulative rate of gait disturbance was lower among patients with p.Pro206Leu or p.Val263Gly mutations than among those homozygous for the c.689_690insT mutation (P\u2009=\u20090.001). The cumulative rate of inability to walk without assistance was higher in patients homozygous for the c.689_690insT mutation than in those with p.Pro206Leu or p.Val263Gly mutations (P\u2009=\u20090.004). Using a Cox proportional hazards model, we found that the homozygous c.689_690insT mutation was associated with an increased risk for onset of gait disturbance (adjusted hazard ratio: 6.60) and for the inability to walk without assistance (adjusted hazard ratio: 2.99). All patients homozygous for the c.689_690insT mutation presented ocular motor apraxia at &amp;lt;15 years of age. Approximately half the patients homozygous for the c.689_690insT mutation developed cognitive impairment. In contrast, in the patients with p.Pro206Leu or p.Val263Gly mutations, only \u223c50% of the patients exhibited ocular motor apraxia and they never developed cognitive impairment. The stepwise multivariate regression analysis using sex, age and the number of c.689_690insT alleles as independent variables revealed that the number of c.689_690insT alleles was independently and negatively correlated with median motor nerve conduction velocities, ulnar motor nerve conduction velocities and values of serum albumin. In the patient with c.[689_690insT]+[840delT], p.[Pro206Leu]+[Pro206Leu] and p.[Pro206Leu]+[Val263Gly] mutations, aprataxin proteins were not detected by an antibody to the N-terminus of aprataxin. Furthermore Pro206Leu and Val263Gly aprataxin proteins are unstable. However, the amount of the 689_690insT aprataxin messenger RNA was also decreased, resulting in more dramatic reduction in the amount of aprataxin protein from the c.689_690insT allele. In conclusion, patients with early onset ataxia with ocular motor apraxia and hypoalbuminaemia homozygous for the c.689_690insT mutation show a more severe phenotype than those with a p.Pro206Leu or p.Val263Gly mutation.<\/jats:p>","DOI":"10.1093\/brain\/awr069","type":"journal-article","created":{"date-parts":[[2011,4,12]],"date-time":"2011-04-12T20:56:51Z","timestamp":1302641811000},"page":"1387-1399","source":"Crossref","is-referenced-by-count":29,"title":["Genotype\u2013phenotype correlations in early onset ataxia with ocular motor apraxia and hypoalbuminaemia"],"prefix":"10.1093","volume":"134","author":[{"given":"Akio","family":"Yokoseki","sequence":"first","affiliation":[{"name":"1 1 Department of Neurology, Clinical Neuroscience Branch, Brain Research Institute, Niigata University, 1-757 Asahimachi-dori, Chuo-ku, Niigata-City, Niigata 951-8585, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiko","family":"Ishihara","sequence":"additional","affiliation":[{"name":"1 1 Department of Neurology, Clinical Neuroscience Branch, Brain Research Institute, Niigata University, 1-757 Asahimachi-dori, Chuo-ku, Niigata-City, Niigata 951-8585, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihide","family":"Koyama","sequence":"additional","affiliation":[{"name":"1 1 Department of Neurology, Clinical Neuroscience Branch, Brain Research Institute, Niigata University, 1-757 Asahimachi-dori, Chuo-ku, Niigata-City, Niigata 951-8585, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Shiga","sequence":"additional","affiliation":[{"name":"1 1 Department of Neurology, Clinical Neuroscience Branch, Brain Research Institute, Niigata University, 1-757 Asahimachi-dori, Chuo-ku, Niigata-City, Niigata 951-8585, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsunori","family":"Yamada","sequence":"additional","affiliation":[{"name":"2 2 Department of Clinical Research, National Hospital Organization, Saigata National Hospital, 468-1 Saigata, Ohgata-ku, Johetsu-city, Niigata 949-3193, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chieko","family":"Suzuki","sequence":"additional","affiliation":[{"name":"3 3 Department of Neurology, Aomori Prefectual Chuo Hospital, 2-1-1, Higashitsukurimichi, Aomori-city, Aomori 030-8553, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Sekijima","sequence":"additional","affiliation":[{"name":"4 4 Department of Neurology and Rheumatology, Division of Clinical and Molecular Genetics, Shinshu University Hospital, 3-1-1 Asahi, Matsumoto 390-8621, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoko","family":"Maruta","sequence":"additional","affiliation":[{"name":"5 5 Department of Neurology, National Hospital Organization, Minamikyushu Hospital, 1882 Kida, Kajikicho, Aira-City, Kagoshima 899-5293, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miyuki","family":"Tsuchiya","sequence":"additional","affiliation":[{"name":"6 6 Department of Molecular Neuroscience, Resource Branch for Brain Disease Research, Centre for Bioresource-based Research, Brain Research Institute, Niigata University, 1-757 Asahimachi-dori, Chuo-ku, Niigata-City, Niigata 951-8585, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetoshi","family":"Date","sequence":"additional","affiliation":[{"name":"7 7 Department of Neurology, Graduate School of Medicine, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo 113-8655, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Sato","sequence":"additional","affiliation":[{"name":"1 1 Department of Neurology, Clinical Neuroscience Branch, Brain Research Institute, Niigata University, 1-757 Asahimachi-dori, Chuo-ku, Niigata-City, Niigata 951-8585, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayoshi","family":"Tada","sequence":"additional","affiliation":[{"name":"1 1 Department of Neurology, Clinical Neuroscience Branch, Brain Research Institute, Niigata University, 1-757 Asahimachi-dori, Chuo-ku, Niigata-City, Niigata 951-8585, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Ikeuchi","sequence":"additional","affiliation":[{"name":"6 6 Department of Molecular Neuroscience, Resource Branch for Brain Disease Research, Centre for Bioresource-based Research, Brain Research Institute, Niigata University, 1-757 Asahimachi-dori, Chuo-ku, Niigata-City, Niigata 951-8585, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoji","family":"Tsuji","sequence":"additional","affiliation":[{"name":"7 7 Department of Neurology, Graduate School of Medicine, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo 113-8655, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoyo","family":"Nishizawa","sequence":"additional","affiliation":[{"name":"1 1 Department of Neurology, Clinical Neuroscience Branch, Brain Research Institute, Niigata University, 1-757 Asahimachi-dori, Chuo-ku, Niigata-City, Niigata 951-8585, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Onodera","sequence":"additional","affiliation":[{"name":"6 6 Department of Molecular Neuroscience, Resource Branch for Brain Disease Research, Centre for Bioresource-based Research, Brain Research Institute, Niigata University, 1-757 Asahimachi-dori, Chuo-ku, Niigata-City, Niigata 951-8585, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2011,4,12]]},"reference":[{"key":"2026101208311219000_B1","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/nature05164","article-title":"The neurodegenerative disease protein aprataxin resolves abortive DNA ligation intermediates","volume":"443","author":"Ahel","year":"2006","journal-title":"Nature"},{"key":"2026101208311219000_B2","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/ana.410240404","article-title":"Ataxia-ocular motor apraxia: a syndrome mimicking ataxia-telangiectasia","volume":"24","author":"Aicardi","year":"1988","journal-title":"Ann Neurol"},{"key":"2026101208311219000_B3","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1212\/01.WNL.0000137044.06573.46","article-title":"Aprataxin gene mutations in Tunisian families","volume":"63","author":"Amouri","year":"2004","journal-title":"Neurology"},{"key":"2026101208311219000_B4","first-page":"355","article-title":"A case of congenital ocular motor apraxia with cerebellospinal degeneration","volume":"21","author":"Araie","year":"1977","journal-title":"Jpn J Opthalmol"},{"key":"2026101208311219000_B5","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1001\/archneur.58.2.201","article-title":"Recessive ataxia with ocular apraxia: review of 22 Portuguese patients","volume":"58","author":"Barbot","year":"2001","journal-title":"Arch Neurol"},{"key":"2026101208311219000_B6","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/nrg2380","article-title":"Single-strand break repair and genetic disease","volume":"9","author":"Caldecott","year":"2008","journal-title":"Nat Rev Genet"},{"key":"2026101208311219000_B7","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/ana.20463","article-title":"Very late onset in ataxia oculomotor apraxia type I","volume":"57","author":"Criscuolo","year":"2005","journal-title":"Ann Neurol"},{"key":"2026101208311219000_B8","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1212\/01.WNL.0000145604.57000.36","article-title":"Ataxia with oculomotor apraxia type 1 in Southern Italy: late onset and variable phenotype","volume":"63","author":"Criscuolo","year":"2004","journal-title":"Neurology"},{"key":"2026101208311219000_B9","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1177\/0883073808314959","article-title":"Ataxia with oculomotor apraxia type 1 (AOA1): clinical and neuropsychological features in 2 new patients and differential diagnosis","volume":"23","author":"D'Arrigo","year":"2008","journal-title":"J Child Neurol"},{"key":"2026101208311219000_B10","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/ng1001-184","article-title":"Early-onset ataxia with ocular motor apraxia and hypoalbuminemia is caused by mutations in a new histidine triad superfamily gene","volume":"29","author":"Date","year":"2001","journal-title":"Nat Genet"},{"key":"2026101208311219000_B11","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jns.2007.05.015","article-title":"A novel mutation of aprataxin associated with ataxia ocular apraxia type 1: phenotypical and genotypical characterization","volume":"260","author":"Ferrarini","year":"2007","journal-title":"J Neurol Sci"},{"key":"2026101208311219000_B12","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1093\/hmg\/ddh122","article-title":"Aprataxin, a novel protein that protects against genotoxic stress","volume":"13","author":"Gueven","year":"2004","journal-title":"Hum Mol Genet"},{"key":"2026101208311219000_B13","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s00415-004-0374-7","article-title":"Aprataxin mutations are a rare cause of early onset ataxia in Germany","volume":"251","author":"Habeck","year":"2004","journal-title":"J Neurol"},{"key":"2026101208311219000_B14","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.neulet.2007.04.044","article-title":"Short half-lives of ataxia-associated aprataxin proteins in neuronal cells","volume":"419","author":"Hirano","year":"2007","journal-title":"Neurosci Lett"},{"key":"2026101208311219000_B15","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/01658107.1992.11978666","article-title":"Friedreich's ataxia associated with congenital ocular motor apraxia","volume":"12","author":"Kurita-Tashima","year":"1992","journal-title":"Neuro Ophthalmology"},{"key":"2026101208311219000_B16","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.molmed.2006.05.005","article-title":"Applying nonsense-mediated messenger RNA decay research to the clinic: progress and challenges","volume":"12","author":"Kuzmiak","year":"2006","journal-title":"Trends Mol Med"},{"issue":"Pt 12","key":"2026101208311219000_B17","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1093\/brain\/awg283","article-title":"Cerebellar ataxia with oculomotor apraxia type 1: clinical and genetic studies","volume":"126","author":"Le Ber","year":"2003","journal-title":"Brain"},{"key":"2026101208311219000_B18","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1177\/088307380502000610","article-title":"Familial cognitive impairment with ataxia with oculomotor apraxia","volume":"20","author":"Mahajnah","year":"2005","journal-title":"J Child Neurol"},{"key":"2026101208311219000_B19","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1086\/318191","article-title":"Homozygosity mapping of Portuguese and Japanese forms of ataxia-oculomotor apraxia to 9p13, and evidence for genetic heterogeneity","volume":"68","author":"Moreira","year":"2001","journal-title":"Am J Hum Genet"},{"key":"2026101208311219000_B20","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/ng1001-189","article-title":"The gene mutated in ataxia-ocular apraxia 1 encodes the new histidine triad\/Zn-finger protein aprataxin","volume":"29","author":"Moreira","year":"2001","journal-title":"Nat Genet"},{"key":"2026101208311219000_B21","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1440-1789.2006.00741.x","article-title":"Spinocerebellar ataxia with ocular motor apraxia and DNA repair","volume":"26","author":"Onodera","year":"2006","journal-title":"Neuropathology"},{"key":"2026101208311219000_B22","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/ana.10808","article-title":"Aprataxin, the causative protein for EAOH is a nuclear protein with a potential role as a DNA repair protein","volume":"55","author":"Sano","year":"2004","journal-title":"Ann Neurol"},{"key":"2026101208311219000_B23","doi-asserted-by":"crossref","first-page":"20927","DOI":"10.1074\/jbc.M502889200","article-title":"Disease-associated mutations inactivate AMP-lysine hydrolase activity of Aprataxin","volume":"280","author":"Seidle","year":"2005","journal-title":"J Biol Chem"},{"key":"2026101208311219000_B24","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1017\/S0012162206001113","article-title":"Atypical presentation of ataxia-oculomotor apraxia type 1","volume":"48","author":"Shahwan","year":"2006","journal-title":"Dev Med Child Neurol"},{"key":"2026101208311219000_B25","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1212\/WNL.59.4.590","article-title":"Early-onset ataxia with ocular motor apraxia and hypoalbuminemia: the aprataxin gene mutations","volume":"59","author":"Shimazaki","year":"2002","journal-title":"Neurology"},{"key":"2026101208311219000_B26","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4419-6448-9_3","article-title":"Early-onset ataxia with ocular motor apraxia and hypoalbuminemia\/ataxia with oculomotor apraxia 1","volume-title":"Diseases of DNA repair","author":"Tada","year":"2010"},{"key":"2026101208311219000_B27","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1093\/nar\/gkm158","article-title":"Aprataxin, causative gene product for EAOH\/AOA1, repairs DNA single-strand breaks with damaged 3'-phosphate and 3'-phosphoglycolate ends","volume":"35","author":"Takahashi","year":"2007","journal-title":"Nucleic Acids Res"},{"key":"2026101208311219000_B28","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1212\/01.WNL.0000048562.88536.A4","article-title":"Phenotypic variability of aprataxin gene mutations","volume":"60","author":"Tranchant","year":"2003","journal-title":"Neurology"},{"key":"2026101208311219000_B29","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1136\/jnnp.2007.127233","article-title":"Complete deletion of the aprataxin gene: ataxia with oculomotor apraxia type 1 with severe phenotype and cognitive deficit","volume":"79","author":"Yoon","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Brain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/brain\/article-pdf\/134\/5\/1387\/71871690\/brain_134_5_1387.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/brain\/article-pdf\/134\/5\/1387\/71871690\/brain_134_5_1387.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T12:31:22Z","timestamp":1791808282000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/brain\/article\/134\/5\/1387\/286423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4,12]]},"references-count":29,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2011,4,12]]},"published-print":{"date-parts":[[2011,5,1]]}},"URL":"https:\/\/doi.org\/10.1093\/brain\/awr069","relation":{},"ISSN":["1460-2156","0006-8950"],"issn-type":[{"value":"1460-2156","type":"electronic"},{"value":"0006-8950","type":"print"}],"subject":[],"published-other":{"date-parts":[[2011,5]]},"published":{"date-parts":[[2011,4,12]]}}}